Vasoactive and Inotropic Agents

Vasoactive and inotropic agents are drugs used to support the circulation in shock and other states of cardiovascular instability. Vasopressors raise blood pressure mainly by constricting blood vessels, while inotropes increase the force of the heart's contraction; many agents act through adrenergic (sympathomimetic) receptors, and most are given by continuous intravenous infusion and titrated to a haemodynamic target.

Definition

Vasoactive and inotropic agents are pharmacologic drugs that modify vascular tone or myocardial contractility to support arterial pressure and tissue perfusion in shock and acute cardiovascular failure, typically administered as titrated continuous intravenous infusions.

Scope

The topic covers the main classes of circulatory-support drugs encountered in critical and emergency care, the receptor mechanisms by which they act, the haemodynamic targets to which they are titrated, and the monitoring and safety considerations of high-alert continuous infusions. It is a reference and educational overview and does not provide dosing, drug-selection, or treatment recommendations for individual patients.

Core questions

• How do vasopressors and inotropes differ in their effect on vascular tone versus cardiac contractility?
• Through which receptors do the common sympathomimetic agents act, and how does that shape their haemodynamic effect?
• To what physiologic targets are these infusions titrated, and what monitoring and access do they require?

Key concepts

• Vasopressor versus inotrope
• Adrenergic (alpha and beta) receptor activity
• Mean arterial pressure as a titration target
• Continuous infusion and titration
• Central venous access and extravasation risk
• Non-catecholamine vasopressors (e.g., vasopressin)
• Shock states and circulatory support

Mechanisms

Many vasoactive drugs are sympathomimetics that act on adrenergic receptors: alpha-1 stimulation constricts vessels and raises systemic vascular resistance, while beta-1 stimulation increases heart rate and contractility. Norepinephrine combines strong alpha effect with some beta activity and is widely used as a first-line vasopressor; dopamine acts on dopaminergic and adrenergic receptors in a manner that varies with infusion rate; and inotropes such as dobutamine act mainly on beta-1 receptors to raise contractility. Vasopressin works through a separate, non-adrenergic vasoconstrictor pathway. Because effect depends on continuous delivery, these drugs are infused and titrated to a haemodynamic target such as mean arterial pressure, an approach reflected in randomized comparisons of agents and of pressure targets.

Clinical relevance

Vasoactive and inotropic agents are among the most safety-critical infusions in intensive and emergency care: small changes in rate produce rapid haemodynamic effects, and extravasation of potent vasoconstrictors can injure tissue, so they typically require close monitoring and secure vascular access. Understanding their classes and targets informs how nurses observe haemodynamics, interpret trends, and recognize problems. This entry describes how the therapy is organized and monitored and is not a source of dosing or individualized treatment advice.

Evidence & guidelines

Randomized trials have compared individual agents and pressure targets — dopamine versus norepinephrine in shock, vasopressin versus norepinephrine in septic shock, and higher versus lower mean arterial pressure targets — and their findings are synthesized in the Surviving Sepsis Campaign guidelines, which many units use as a reference for haemodynamic support. These sources describe how care is generally organized rather than directing treatment of an individual patient.

History

Adrenergic vasopressors and inotropes entered intensive care as the pharmacology of the autonomic nervous system was mapped onto receptor subtypes and as infusion technology made precise titration possible. Later randomized trials refined which agents and pressure targets are preferred in shock, and successive Surviving Sepsis Campaign documents consolidated these comparisons into widely cited reference guidance.

Debates

Which vasopressor should be first-line in septic shock?

Randomized comparison of dopamine and norepinephrine and of vasopressin and norepinephrine informed a general preference for norepinephrine as the initial agent, with other vasopressors used as adjuncts, though the comparative role of each agent remains an active question.

What blood-pressure target should vasopressors aim for?

A trial comparing higher and lower mean arterial pressure targets in septic shock found no overall mortality difference, leaving the optimal target a matter of judgement that may depend on patient factors.

Seminal works

• debacker-2010
• russell-2008
• asfar-2014

Frequently asked questions

What is the difference between a vasopressor and an inotrope?

A vasopressor mainly raises blood pressure by constricting blood vessels, increasing vascular resistance. An inotrope mainly increases the force of the heart's contraction. Some drugs have both effects, and the two kinds of agents are sometimes used together depending on the cause of circulatory failure.

Why are vasoactive drugs usually given by continuous infusion?

These agents act quickly and wear off quickly, so giving them as a steady, adjustable infusion allows the dose to be titrated to a measured haemodynamic target. This precision is also why they are treated as high-alert medications requiring close monitoring.